Lexicon Pharma (LXRX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.01 -1.47%
Revenue Growth %: -86.1%
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -86.1%
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q3 EPS of ($0.34), $0.02 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $566 thousand versus the consensus estimate of $370 thousand.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Kroger meets earnings expectations, revenue tops estimates
- Micron Technology (MU) PT Raised to $1,300 at Bernstein SocGen Group
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
